The US Food and Drug Administration (FDA) has granted marketing authorisation for LumiThera’s Valeda Light Delivery System to ...
The company’s new AI chip looks like a runaway hit. Why the shares might resume their long-term rise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback